|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu Y, Jiang Q, Liu H, Xiao X, Yang D, Saw
PE and Luo B: DHX37 impacts prognosis of hepatocellular carcinoma
and lung adenocarcinoma through immune infiltration. J Immunol Res.
2020:88353932020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu Y, Liu Z, Li H, Feng S, Li Q, Li J and
Li S: VEGI downregulation is correlated with nodal metastasis and
poor prognosis in lung adenocarcinoma. Mol Clin Oncol. 14:252021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai J, Deng H, Luo L, You L, Liao H and
Zheng Y: Decreased expression of JAK1 associated with immune
infiltration and poor prognosis in lung adenocarcinoma. Aging
(Albany NY). 13:2073–2088. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robinson AD, Eich ML and Varambally S:
Dysregulation of de novo nucleotide biosynthetic pathway enzymes in
cancer and targeting opportunities. Cancer Lett. 470:134–140. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lv Y, Wang X, Li X, Xu G, Bai Y, Wu J,
Piao Y, Shi Y, Xiang R and Wang L: Nucleotide de novo synthesis
increases breast cancer stemness and metastasis via cGMP-PKG-MAPK
signaling pathway. PLoS Biol. 18:e30008722020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan TWM, Bruntz RC, Yang Y, Song H,
Chernyavskaya Y, Deng P, Zhang Y, Shah PP, Beverly LJ, Qi Z, et al:
De novo synthesis of serine and glycine fuels purine nucleotide
biosynthesis in human lung cancer tissues. J Biol Chem.
294:13464–13477. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamaoka T, Kondo M, Honda S, Iwahana H,
Moritani M, Ii S, Yoshimoto K and Itakura M:
Amidophosphoribosyltransferase limits the rate of cell
growth-linked de novo purine biosynthesis in the presence of
constant capacity of salvage purine biosynthesis. J Biol Chem.
272:17719–17725. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verma P, Kar B, Varshney R, Roy P and
Sharma AK: Characterization of AICAR transformylase/IMP
cyclohydrolase (ATIC) from Staphylococcus lugdunensis. FEBS
J. 284:4233–4261. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li R, Chen G, Dang Y, He R, Liu A, Ma J
and Wang C: Upregulation of ATIC in multiple myeloma tissues based
on tissue microarray and gene microarrays. Int J Lab Hematol.
43:409–417. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li M, Jin C, Xu M, Zhou L, Li D and Yin Y:
Bifunctional enzyme ATIC promotes propagation of hepatocellular
carcinoma by regulating AMPK-mTOR-S6 K1 signaling. Cell
communication and signaling. Cell Commun Signal. 15:522017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsieh AL, Walton ZE, Altman BJ, Stine ZE
and Dang CV: MYC and metabolism on the path to cancer. Semin Cell
Dev Biol. 43:11–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dang CV: MYC on the path to cancer. Cell.
149:22–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zack TI, Schumacher SE, Carter SL,
Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhsng CZ, Wala J,
Mermel CH, et al: Pan-cancer patterns of somatic copy number
alteration. Nat Genet. 45:1134–1140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen P, Reineke LC, Knutsen E, Chen M,
Pichler M, Ling H and Calin GA: Metformin blocks MYC protein
synthesis in colorectal cancer via mTOR-4EBP-eIF4E and
MNK1-eIF4G-eIF4E signaling. Mol Oncol. 12:1856–1870. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu D, Xie R, Xu Z, Zhao Z, Ding M, Chen W,
Zhang J, Mao E, Chen E, Chen Y, et al: mTOR-Myc axis drives
acinar-to-dendritic cell transition and the CD4+ T cell
immune response in acute pancreatitis. Cell Death Dis. 11:4162020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greasley SE, Horton P, Ramcharan J,
Beardsley GP, Benkovic SJ and Wilson IA: Crystal structure of a
bifunctional transformylase and cyclohydrolase enzyme in purine
biosynthesis. Nat Struct Biol. 8:402–406. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vergis JM, Bulock KG, Fleming KG and
Beardsley GP: Human 5-aminoimidazole-4-carboxamide ribonucleotide
transformylase/inosine 5′-monophosphate cyclohydrolase. A
bifunctional protein requiring dimerization for transformylase
activity but not for cyclohydrolase activity. J Biol Chem.
276:7727–7733. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Racanelli AC, Rothbart SB, Heyer CL and
Moran RG: Therapeutics by cytotoxic metabolite accumulation:
Pemetrexed causes ZMP accumulation, AMPK activation, and mammalian
target of rapamycin inhibition. Cancer Res. 69:5467–5474. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park JA and Shin HY: ATIC gene
polymorphism and histologic response to chemotherapy in pediatric
osteosarcoma. J Pediatr Hematol Oncol. 39:e270–e274. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu J, Wang M and Hu D: Development of an
autophagy-related gene prognostic signature in lung adenocarcinoma
and lung squamous cell carcinoma. PeerJ. 8:e82882020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iwakawa R, Kohno T, Kato M, Shiraishi K,
Tsuta K, Noguchi M, Ogawa S and Yokota J: MYC amplification as a
prognostic marker of early-stage lung adenocarcinoma identified by
whole genome copy number analysis. Clin Cancer Res. 17:1481–1489.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ciribilli Y and Borlak J: Oncogenomics of
c-Myc transgenic mice reveal novel regulators of extracellular
signaling, angiogenesis and invasion with clinical significance for
human lung adenocarcinoma. Oncotarget. 8:101808–101831. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei C and Dong X, Lu H, Tong F, Chen L,
Zhang R, Dong J, Hu Y, Wu G and Dong X: LPCAT1 promotes brain
metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC
pathway. J Exp Clin Cancer Res. 38:952019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fan G, Xu P and Tu P: miR-1827 functions
as a tumor suppressor in lung adenocarcinoma by targeting MYC and
FAM83F. J Cell Biochem. 121:1675–1689. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cunningham JT, Moreno MV, Lodi A, Ronen SM
and Ruggero D: Protein and nucleotide biosynthesis are coupled by a
single rate-limiting enzyme, PRPS2, to drive cancer. Cell.
157:1088–1103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barfeld SJ, Fazli L, Persson M, Marjavaara
L, Urbanucci A, Kaukoniemi KM, Rennie PS, Ceder Y, Chabes A,
Visakorpi T and Mills IG: Myc-dependent purine biosynthesis affects
nucleolar stress and therapy response in prostate cancer.
Oncotarget. 6:12587–12602. 2015. View Article : Google Scholar : PubMed/NCBI
|
